What does CUSIP 60855D101 represent in this 13F holders report?

CUSIP 60855D101 is the security identifier for MBRX - MOLECULIN BIOTECH INC - COM used to aggregate holder disclosures.

How many institutions held MBRX - MOLECULIN BIOTECH INC - COM in Q4 2016?

9 institutional investors reported MBRX - MOLECULIN BIOTECH INC - COM for Q4 2016. Use the holders table for investor-level position and value details.

MOLECULIN BIOTECH INC - COM (MBRX)

CUSIP: 60855D101

Q4 2016 13F Holders as of 31 Dec 2016

Security type / class: Equity / COM
Total 13F shares: 92,348
Total 13F value: $211,000
Share change: +49,822
SEC-reported price per share: $2.28
Number of holders: 9
Value change: -$10,212
Number of buys: 6
Number of sells: 5

Security key

60855D101

Report period

Q4 2016

Institutions

Top holders

MBRX full security history Ownership snapshot Full 13F holder table Moleculin Biotech, Inc. SEC filings Moleculin Biotech, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of MBRX - MOLECULIN BIOTECH INC - COM (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

ING GROEP NV

Disclosed value leader

ING GROEP NV

Comparable rows

0/9

Latest evidence

30 Sep 2016

13F Highest disclosed value: $122,000 9 rows are not safely comparable across share classes. Showing 1-6 of 9 holder rows.

Quick read

ING GROEP NV has the largest disclosed position value at $122K.

0 of 9 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens ING GROEP NV's linked filing trail.

Disclosed position value Top 5

ING GROEP NV $122K

Virtu KCG Holdings LLC $66K

CITIGROUP INC $29K

UBS Group AG $14K

Acrospire Investment Management LLC $9K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 9 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
ING GROEP NV	13F Company 13F	— denominator unverified	$122,000 20,000 shares	—	30 Sep 2016
Virtu KCG Holdings LLC	13F Company 13F	— denominator unverified	$66,000 11,614 shares	—	30 Sep 2016
CITIGROUP INC	13F Company 13F	— denominator unverified	$29,000 5,000 shares	—	30 Sep 2016
UBS Group AG	13F Company 13F	— denominator unverified	$14,000 2,495 shares	—	30 Sep 2016
Acrospire Investment Management LLC	13F Company 13F	— denominator unverified	$9,000 1,600 shares	—	30 Sep 2016
Tower Research Capital LLC (TRC)	13F Company 13F	— denominator unverified	$5,000 917 shares	—	30 Sep 2016

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2016

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

92,348

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2016 vs Q3 2016 Across Filers

Q3 2016 holders

Q4 2016 holders

Holder diff

Investor	Q3 2016 Shares	Q4 2016 Shares	Share Diff	Share Chg %	Q3 2016 value	Q4 2016 value	Value change	Value Chg %